Skip to main content
Premium Trial:

Request an Annual Quote

Foss Subsidiary to Distribute Warnex Detection Systems in UK, Ireland

NEW YORK, May 16 (GenomeWeb News) - Warnex said yesterday that Foss UK, a subsidiary of Danish firm Foss, will distribute and market Warnex's Rapid Pathogen Detection System in the UK and Ireland.

 

Foss UK, based in Warrington, will replace Warnex's previous distributor, Don Whitley Scientific.

 

Additional terms were not disclosed.

 

The Rapid Pathogen Detection System uses DNA-based technology to determine the presence of pathogens in a sample.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.